| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07226349 A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced… |
Trial sites expanded: 18 -> 21 locations |
| 2026-06-04 | NCT07492641 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… |
Trial sites expanded: 4 -> 13 locations |
| 2026-06-02 | NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… |
Enrollment reduced: 258 -> 103 participants |
| 2026-06-02 | NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… |
date change Primary completion moved earlier: 2028-04 -> 2026-08-31 |
| 2026-06-02 | NCT06257264 A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… |
date change Completion moved earlier: 2028-07 -> 2026-08-31 |
| 2026-05-23 | NCT07492641 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… |
Recruitment opened |
| 2026-05-23 | NCT07492641 BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… |
Trial sites expanded: 0 -> 4 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07492641 | BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or… | HR+/HER2- Breast Cancer | Recruiting |
| Phase 1 | |||
| NCT06120283 | BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer… | Advanced Solid Tumor | Recruiting |
| NCT07226349 | A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced… | Advanced Solid Tumor | Recruiting |
| NCT06756932 | BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive… | Hormone-receptor-positive Breast Cancer | Recruiting |
| NCT06257264 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With… | Breast Cancer | Active, Not Recruiting |